Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Post by caretired1on Jan 17, 2024 10:28am
195 Views
Post# 35831107

Please email below to Health Canada Expert Review Board

Please email below to Health Canada Expert Review Boardlegreview-examenleg@hc-sc.gc.ca  is the address, the time is now to help our industry

To the Health Canada Expert Panel on Cannabis
 
I am writing to impress upon you the need to increase the THC limits in edibles packages.  Currently the limit is 10mg per package.  This creates an uncompetitive price per gram to the illicit market whose products are still widely available on a convenient delivery to door basis.
I understand that the case numbers relating to hospital admissions due to overdosing or other health issues arising from legal edibles acquired are near zero whereas illicit product continues to create significant case counts.
If dosing in legal edibles was increased to 100mg per package, the price of the product would be competitive to illicit product and would enable and encourage me to buy safe, tax generating legal product, which I would prefer.
This would be the main reason to bring me to the legal edible market as a buyer.
Please recommend this change on package limits of edibles to increase to 100mg for the upcoming March report to Parliament.
Thank you.

<< Previous
Bullboard Posts
Next >>